Jade Biosciences, Inc.
JBIO
$13.97
-$0.28-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.42% | 3.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.66% | -1.36% | |||
| Operating Income | -27.66% | 1.36% | |||
| Income Before Tax | -26.61% | 21.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.84% | 21.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.84% | 21.66% | |||
| EBIT | -27.66% | 1.36% | |||
| EBITDA | -27.68% | 1.39% | |||
| EPS Basic | -2.72% | 44.16% | |||
| Normalized Basic EPS | 7.17% | 30.32% | |||
| EPS Diluted | -2.72% | 44.16% | |||
| Normalized Diluted EPS | 7.17% | 30.32% | |||
| Average Basic Shares Outstanding | 36.39% | 39.23% | |||
| Average Diluted Shares Outstanding | 36.39% | 39.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||